top of page
Profile
Join date: Jun 29, 2021
Posts (24)
Mar 23, 2026 ∙ 1 min
Case Report: Equine allogeneic umbilical cord blood mesenchymal stromal cells (CB-MSC) as adjunctive therapy in a foal with septic arthritis and osteomyelitis
The use of TLR3-activated CB-MSCs may have supported antimicrobial treatment, highlighting the potential antimicrobial, anti-inflammatory, and immunomodulatory properties of CB-MSCs.
8
0
Mar 23, 2026 ∙ 2 min
Treatment outcomes for equine osteoarthritis with mesenchymal stromal cells and hyaluronic acid
This study aimed to assess MSC treatment safety and efficacy. Higher return-to-exercise rates were expected in the MSC groups at 18 weeks, but unexpectedly high rates in the HA group may have led to underpowering. A post hoc calculation suggests 30 horses per group would be needed to detect significant differences.
9
0
Jun 10, 2025 ∙ 1 min
A Pilot Study to Assess the Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for the Treatment of Synovitis in Horses
A study assessed the safety and efficacy of a single administration of 10 million cryopreserved allogeneic mesenchymal stromal cells (MSC) that were either activated (aMSC) or non-activated (naMSC) for the treatment of synovitis.
98
0
eqcellwebmaster
Admin
More actions
bottom of page
